UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061693
Receipt number R000070592
Scientific Title LOW-PRESSURE VERSUS HIGH-PRESSURE HYDRODISTENTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS): A RANDOMISED CONTROLLED TRIAL
Date of disclosure of the study information 2026/05/26
Last modified on 2026/05/26 14:40:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

LOW-PRESSURE VERSUS HIGH-PRESSURE HYDRODISTENTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS): A RANDOMISED CONTROLLED TRIAL

Acronym

LOW-PRESSURE VERSUS HIGH-PRESSURE HYDRODISTENTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS): A RANDOMISED CONTROLLED TRIAL

Scientific Title

LOW-PRESSURE VERSUS HIGH-PRESSURE HYDRODISTENTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS): A RANDOMISED CONTROLLED TRIAL

Scientific Title:Acronym

LOW-PRESSURE VERSUS HIGH-PRESSURE HYDRODISTENTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS): A RANDOMISED CONTROLLED TRIAL

Region

Asia(except Japan)


Condition

Condition

NTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS)

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the optimal hydrodistention technique for IC/BPS patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. To assess and report the effect of hydrodistention in both groups over a period of 4 weeks

Key secondary outcomes

1. To compare the symptom improvement among the patients undergoing high pressure vs low-pressure hydrodistention at 2 and 4 weeks
2. To compare the adverse events between the two groups


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Intervention arm- Group A- Cystoscopy and bladder filling with saline reservoir at a height of 30cm and distention for 3 minutes

Interventions/Control_2

Control arm- Group B- Cystoscopy and bladder filling with saline reservoir at a height of 80cm and distention for 5 minutes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed with IC/BPS and undergoing cystoscopy and hydrodistention as a therapeutic modality
2. Age more than 18 years

Key exclusion criteria

1. Age <18 years
2. Patients not willing to participate in the study
3. Patients who have cystoscopic findings that are suggestive of an alternate diagnosis

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Vibhu
Middle name
Last name Jain

Organization

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA

Division name

DEPARTMENT OF UROLOGY

Zip code

160012

Address

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, SECTOR 12, CHANDIGARH, INDIA

TEL

91-7888498913

Email

jainvibhu26@gmail.com


Public contact

Name of contact person

1st name Vibhu
Middle name
Last name Jain

Organization

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA

Division name

DEPARTMENT OF UROLOGY

Zip code

160012

Address

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, SECTOR 12, CHANDIGARH, INDIA

TEL

91-7888498913

Homepage URL


Email

jainvibhu26@gmail.com


Sponsor or person

Institute

POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA

Institute

Department

Personal name



Funding Source

Organization

No funding was obtained for this study

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

INSTITUTIONAL ETHICS COMMITTEE, POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA

Address

INSTITUTIONAL ETHICS COMMITTEE, ROOM NO. 6006, 6th FLOOR, PGIMER, CHANDIGARH, INDIA

Tel

911722755266

Email

iecintpgi@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 03 Month 15 Day

Date of IRB

2025 Year 02 Month 07 Day

Anticipated trial start date

2024 Year 03 Month 15 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 26 Day

Last modified on

2026 Year 05 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070592